How you got that clot

Elevated plasma factor VIII predicts recurrent venous thromboembolism.

Written byScience Now
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LONDON, August 17 (SPIS MedWire). An elevated plasma level of factor VIII is a known risk factor for venous thromboembolism but, according to a report in today's New England Journal of Medicine it is also strongly predictive of recurrence of the condition. Kyrle et al from Vienna University Hospital used data from the ongoing Austrian Study on Recurrent Venous Thrombosis to prospectively evaluate the relationship between raised factor VIII levels and recurrence in 360 patients who had already had a first episode of venous thrombosis. Over an average follow-up period of 30 months, during which oral anticoagulation was discontinued, 38 patients had recurrence of thromboembolism (24 deep vein thrombosis, 14 pulmonary embolism). Patients with recurrence had higher mean (±SD) plasma levels of factor VIII than those without recurrence (182±66 vs 157±54 IU/dl, p=0.009). The relative risk of recurrent venous thrombosis was 1.08 (95% CI 1.04–1.12) for each increase of 10 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series